Advertisement
EHC vs MD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EHC is a Buy and MD is a StrongBuy.
EHC's Stochastic Oscillator dives into oversold zone
The Stochastic Oscillator for EHC moved into oversold territory on October 21, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +1.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where EHC advanced for three days, in 192 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
EHC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 187 of 337 cases where EHC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
Bearish Trend Analysis
The 10-day RSI Indicator for EHC moved out of overbought territory on October 19, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 48 similar instances where the indicator moved out of overbought territory. In 20 of the 48 cases, the stock moved lower in the following days. This puts the odds of a move lower at 42%.
The Momentum Indicator moved below the 0 level on October 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EHC as a result. In 43 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 48%.
The Moving Average Convergence Divergence Histogram (MACD) for EHC turned negative on October 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 21 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 44%.
EHC moved below its 50-day moving average on October 19, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EHC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.
The Tickeron SMR rating for this company is 38 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. EHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.575) is normal, around the industry mean (204.137). P/E Ratio (19.368) is within average values for comparable stocks, (19.387). Projected Growth (PEG Ratio) (0.610) is also within normal values, averaging (2.498). Dividend Yield (0.007) settles around the average of (0.095) among similar stocks. P/S Ratio (2.021) is also within normal values, averaging (2.688).
MD in upward trend: 10-day moving average moved above 50-day moving average on October 15, 2026
The 10-day moving average for MD crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 83%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on MD as a result. In 63 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.
The Moving Average Convergence Divergence (MACD) for MD just turned positive on October 08, 2026. Looking at past instances where MD's MACD turned positive, the stock continued to rise in 33 of 44 cases over the following month. The odds of a continued upward trend are 75%.
MD moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.93% 3-day Advance, the price is estimated to grow further. Considering data from situations where MD advanced for three days, in 195 of 299 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
The Aroon Indicator entered an Uptrend today. In 134 of 198 cases where MD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.
Bearish Trend Analysis
The 10-day RSI Indicator for MD moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 20 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
MD broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 38 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. MD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.592) is normal, around the industry mean (204.137). P/E Ratio (13.192) is within average values for comparable stocks, (19.387). Projected Growth (PEG Ratio) (0.120) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.095) among similar stocks. P/S Ratio (1.119) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
EHC | MD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 21 | 40 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 68 Overvalued | 66 Overvalued | |
PROFIT vs RISK RATING 1..100 | 22 | 100 | |
SMR RATING 1..100 | 38 | 46 | |
PRICE GROWTH RATING 1..100 | 45 | 38 | |
P/E GROWTH RATING 1..100 | 65 | 38 | |
SEASONALITY SCORE 1..100 | n/a | 13 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MD's Valuation (66) in the Medical Or Nursing Services industry is in the same range as EHC (68) in the Hospital Or Nursing Management industry. This means that MD’s stock grew similarly to EHC’s over the last 12 months.
EHC's Profit vs Risk Rating (22) in the Hospital Or Nursing Management industry is significantly better than the same rating for MD (100) in the Medical Or Nursing Services industry. This means that EHC’s stock grew significantly faster than MD’s over the last 12 months.
EHC's SMR Rating (38) in the Hospital Or Nursing Management industry is in the same range as MD (46) in the Medical Or Nursing Services industry. This means that EHC’s stock grew similarly to MD’s over the last 12 months.
MD's Price Growth Rating (38) in the Medical Or Nursing Services industry is in the same range as EHC (45) in the Hospital Or Nursing Management industry. This means that MD’s stock grew similarly to EHC’s over the last 12 months.
MD's P/E Growth Rating (38) in the Medical Or Nursing Services industry is in the same range as EHC (65) in the Hospital Or Nursing Management industry. This means that MD’s stock grew similarly to EHC’s over the last 12 months.
| EHC | MD | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 42% | 2 days ago 71% |
| Stochastic ODDS (%) | 2 days ago 73% | 2 days ago 78% |
| Momentum ODDS (%) | 2 days ago 48% | 2 days ago 66% |
| MACD ODDS (%) | 2 days ago 44% | 2 days ago 75% |
| TrendWeek ODDS (%) | 2 days ago 54% | 2 days ago 64% |
| TrendMonth ODDS (%) | 2 days ago 58% | 2 days ago 65% |
| Advances ODDS (%) | 7 days ago 60% | 2 days ago 65% |
| Declines ODDS (%) | 2 days ago 57% | 4 days ago 71% |
| BollingerBands ODDS (%) | 2 days ago 64% | 2 days ago 76% |
| Aroon ODDS (%) | 2 days ago 55% | 2 days ago 68% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EHC’s FA Score shows that 1 FA rating(s) are green while MD’s FA Score has 0 green FA rating(s).
- EHC’s FA Score: 1 green, 4 red.
- MD’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EHC’s TA Score shows that 4 TA indicator(s) are bullish while MD’s TA Score has 6 bullish TA indicator(s).
- EHC’s TA Score: 4 bullish, 5 bearish.
- MD’s TA Score: 6 bullish, 4 bearish.
Price Growth
EHC (@Hospital/Nursing Management) experienced а -4.81% price change this week, while MD (@Hospital/Nursing Management) price change was +3.84% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +1.15%. For the same industry, the average monthly price growth was -3.02%, and the average quarterly price growth was +22.32%.
Reported Earning Dates
EHC is expected to report earnings on Oct 28, 2026.
MD is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Hospital/Nursing Management (+1.15% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
Advertisement
EHC and
Correlation & Price change
A.I.dvisor indicates that over the last year, EHC has been loosely correlated with ENSG. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if EHC jumps, then ENSG could also see price increases.
| Ticker / NAME | Correlation To EHC | 1D Price Change % | ||
|---|---|---|---|---|
| EHC | 100% | -0.99% | ||
| ENSG - EHC | 43% Loosely correlated | -1.51% | ||
| UHS - EHC | 35% Loosely correlated | -1.48% | ||
| THC - EHC | 31% Poorly correlated | -1.17% | ||
| ADUS - EHC | 30% Poorly correlated | -0.07% | ||
| HCA - EHC | 29% Poorly correlated | -1.36% | ||
More | ||||
MD and
Correlation & Price change
A.I.dvisor indicates that over the last year, MD has been loosely correlated with NHC. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if MD jumps, then NHC could also see price increases.